www.discount-online-pharmacy.com

Your reliable supplier of generic medications.

Check yourbonu$
Site search:
Obvious advantage Tell a friend and get discount! Want to give it a try?
Categories list

Generic Fenofibrate - Tricor

Search by letter:ABCDEFGHIJKLMNOPQRSTUVWXYZ
Tricor

Generic Tricor

Fenofibrate 160/200mg

Generic Tricor is used for controlling high cholesterol and triglyceride levels in the blood. It is used in combination with a diet low in cholesterol and saturated fat. Generic Tricor is a lipid-lowering agent. It lowers elevated blood triglyceride levels by making the liver produce fewer triglycerides and increasing the elimination of triglycerides from the blood stream.
More info »

$1.25 Buy now!
Choose Your language:
Social bookmarks:
Testimonials

I though the soft tabs would be strips that melted under your tongue. They are as you know just as hard as hard cialis however dissolve under the tongue in about 20 mins. The flavor is fine. Thanks for getting back to me, - Alan

Our billing is certified by:

Secure shopping certificates


Special Offer!

News

  • Treatment of chronic hemodialysis patients with low-dose fenofibrate ... - 7thSpace Interactive (press release)

    Treatment of chronic hemodialysis patients with low-dose fenofibrate .

  • Santarus' CEO Presents at Bank of America Merrill Lynch 2012 Health Care ... - Seeking Alpha

    Santarus' CEO Presents at Bank of America Merrill Lynch 2012 Health Care .

  • Grace, Formac tout positive results for silica-based delivery - FierceDrugDelivery

    Grace, Formac tout positive results for silica-based deliveryFierceDrugDeliveryIn the trial, researchers evaluated the bioavailability of the cholesterol fighter fenofibrate formulated with the silica platform versus that of Lipanthyl, which has the same API.

  • Grace and Formac Pharmaceuticals Announce Successful Clinical Trial ... - MarketWatch (press release)

    Grace and Formac Pharmaceuticals Announce Successful Clinical Trial .

  • Santarus Reports First Quarter 2012 Financial Results - MarketWatch (press release)

    FISSantarus Reports First Quarter 2012 Financial ResultsMarketWatch (press release)FENOGLIDE(fenofibrate) tablets new prescriptions grew 17% and total prescriptions increased 11% for the four-week period ending April 20, 2012, compared with the four-week period ending February 3, 2012, which was just prior to Santarus' initiation of .

bookmark Bookmark this site
Subscribe to the News



Canada Pharmacy
Canadian Pharmacy

Indian Trusted Rx approved.